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Polymer gel dosimeters in conjunction with the nuclear magnetic resonance imaging 
(MRI) are potentially useful for verification of complex dose distributions in three 
dimensions (3D) applied in radiotherapy treatment planning. The radiation-induced 
normoxic polymer gels of polyhydroxyethylacrylate (PHEAG) and 
polyhydroxyethylmethacrylate (PHEMAG) have been studied using Raman 
spectroscopy and MRI scanner. The studies are focused on PHEAG and PHEMAG 
because these monomers belong to acrylic group. Most of the monomer in the acrylic 
group will indicate physical changes dramatically due to radiation given. The PHEAG 
 iv
and PHEMAG were synthesized from 2-hdroxyethylacrylate (HEA) and 
hydroxyethylmethacrylate (HEMA) monomer (2 to 5% w/w) respectively and 
together with methylene-bis-acrylamide (BIS) crosslinker (1 to 4% w/w), gelatine 
(3% w/w), ascorbic acid (5 mM to 15 mM) and completed with de-ionized water. The 
dosimeters were irradiated with 60Co teletherapy γ-rays source at a constant dose rate 
of 0.177 Gy/min, receiving doses up 20 Gy for the single point dose measurement and 
the 3D dose distributions scanning.  
 
The polymerization intended for PHEMAG was followed by the change of Raman 
intensity at Raman shift of 812 cm-1, 1978 cm-1 and 2885 cm-1 assigned for C-C 
stretching, C=O stretching and CH3 stretching respectively and at 812 cm-1 assigned 
for C-C stretching in favour of PHEAG. The Raman intensity y corresponding to the 
amount of polymer formed in both PHEAG and PHEMAG increases with increasing 
dose D and follows a mono-exponential equation given as ( )0/0 1 DDeAyy −−+= . The 
dose sensitivity 0D  derived from the equation and k factor derived from a linear 
relationship between 0D  and co-monomer concentration were found increasing with 
the increase of initial concentrations of monomer, cross-linker and anti-oxidant. The 
consumptions of co-monomers in PHEAG were studied by a decrease intensity of 
C=C stretching at 2887 cm-1 and 2602 cm-1 of HEA and BIS respectively and at 2602 
cm-1 and 2369 cm-1 of HEMA and BIS respectively in favour of PHEMAG. The 
intensity decreases with increasing dose and follows mono-exponential equation 
given as ( )0/0 1 DDeAyy −−−= . The dose sensitivity 0D  and k factor were also found 
 v
to increase with the increase of monomer, cross-linker and anti-oxidant 
concentrations. 
 
The PHEMAG phantoms synthesized from HEMA monomer (3% w/w), BIS 
crosslinker (2 to 4% w/w), gelatine (3%), anti-oxygen ascorbic acid (15 mM to 55 
mM) and completed with de-ionized water were exposed with single and crossed 
beams to simulate radiotherapy treatment. Magnetic resonance imaging (MRI) 
scanner was used to scan dose distribution of the phantoms and the 3D images were 
evaluated using a digital densitometer. It was found that the absorbed dose decreases 
with the increase of depth dose inside the phantom and the consequently two crossed 
beams of 20 Gy each produced less than 35 Gy beyond 3 cm depth dose. There is a 
slightly increase in dose with the increase of ascorbic acid concentration for all the 
radiation beams tested, indicating the use of ascorbic acid alone as anti-oxidant agent 
in PHEMAG was able to produce normoxic polymer gel dosimeters. Referring to the 
results of dose correlation factor k, it can be concluded that kHEMA is more significant 
than kHEA.  
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Perhubungan antara dosimeter polimer gel dengan MRI berpotensi digunakan untuk 
verifikasi penyerakan dos kompleks dalam bentuk tiga dimensi untuk rawatan 
radioterapi. Radiasi aruhan polimer gel “normoxic” polihidroksietilakrilat (PHEAG) 
dan polihidroksietilmetakrilat (PHEMAG) telah dikaji dengan menggunakan 
spektroskopi Raman and pengimbas MRI. Kajian tertumpu terhadap PHEAG dan 
PHEMAG kerana monomer-monomer ini berada di dalam kumpulan akrilik. 
Kebanyakkan monomer daripada kumpulan akrilik akan menunjukkan perubahan 
fizikal yang ketara akibat sinaran yang diberikan. PHEAG and PHEMAG telah 
 vii
disintesiskan daripada 2-hidroksietilakrilat (HEA) dan 2-hidroksietilmetakrilat 
(HEMA) (2 hingga 5% w/w) masing-masing dan bersama-sama dengan methylene-
bis-acrylamide (BIS) taut-silang (1 hingga 4% w/w), gelatin (3%), asid askorbik (5 
mM hingga 15 mM) dan disudahi dengan air ternyah ion. Dosimeter tersebut telah 
diradiasikan dengan sumber teleterapi sinar-γ 60Co pada kadar tetap 0.177 Gy/min, 
menerima dos sehingga 20 Gy untuk pengukuran dos titik tunggal dan pengimbasan 
taburan dos 3D.  
  
Pempolimeran PHEMAG yang disasarkan telah diikuti dengan perubahan regangan 
anjakan keamatan Raman pada 812 cm-1, 1978 cm-1 dan 2885 cm-1 diwakili untuk 
regangan C-C, regangan C=O dan juga regangan CH3 masing-masing dan pada 812 
cm-1 diwakili untuk regangan C-C terhadap PHEAG. Keamatan Raman y mempunyai 
kesamaan bilangan polimer yang terbentuk di dalam kedua-dua PHEAG dan 
PHEMAG meningkat dengan peningkatan dos D dan mengikut persamaan mono-
eksponen yang dinyatakan sebagai ( )0/0 1 DDeAyy −−+= . Kepekaan dos Do yang 
diperolehi daripada persamaan dan faktor k  yang diperolehi daripada hubungan linear 
antara Do dan kepekatan monomer bersama telah didapati meningkat dengan 
peningkatan  kepekatan pemulaan monomer, taut-silang dan anti-oksida. Penggunaan 
monomer di dalam PHEAG telah dikaji dengan pengurangan keamatan regangan 
C=C pada 2887 cm-1 dan 2602 cm-1 daripada HEA dan BIS masing-masing dan pada 
2602 cm-1 dan  2369 cm-1 daripada HEMA dan BIS masing-masing terhadap 
PHEMAG. Keamatan berkurangan dengan peningkatan dos dan mematuhi persamaan 
mono-eksponen yang diberi sebagai ( )0/0 1 DDeAyy −−−= . Kepekaan dos Do dan 
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faktor k juga didapati meningkat dengan peningkatan monomer, tautan-silang dan 
kepekatan anti-oksida. 
Fentom PHEMAG yang telah disintesis daripada monomer HEMA (3% w/w),  BIS (2 
hingga 4% w/w), gelatin (3%), anti-oksida asid askorbik (15 mM hingga 55 mM) dan 
disudahi dengan air ternyah ion telah didedahkan dengan pancaran tunggal dan silang 
untuk merangsang rawatan radiotherapi. Pengimbas Pengimejan Resonan Magnet 
(MRI) telah digunakan untuk mengimbas taburan dos oleh fentom dan imej 3D telah  
dinilai dengan densitometer digital. Didapati penyerapan dos berkurangan dengan 
peningkatan kedalaman dos di dalam fentom dan menyebabkan dua pancaran silang 
20 Gy setiap satu menghasilkan kurang daripada 35 Gy melangkaui 3 cm kedalaman 
dos. Terdapat sedikit peningkatan di dalam dos dengan peningkatan kepekatan asid 
askorbik untuk semua pancaran radiasi yang telah diuji, menunjukkan penggunaan 
asid askorbik sendirian sebagai agen anti-oksida di dalam PHEMAG boleh 
menghasilkan meter dos polimer gel “normoxic”. Berdasarkan kepada keputusan 
yang diperolehi untuk faktor dos korelasi k, dapt dirumuskan bahawa kHEMA adalah 
lebih menonjol daripada  kHEA.  
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be broken down into stretching single bonds during 
polymerization. 
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Figure 5.2 Chemical structures of (a) 2-Hydroxyethyl Methacrylate 
(HEMA); (b) N, N’-methylene-bisacrylamide (BIS); (c) 
Polyhydroxyethylmethacrylate (PHEMA). The circles 
indicate the affected stretching double bonds of co-
monomers likely to be broken down into stretching single 
bonds during polymerization. 
 
5.6 
Figure 5.3 Initiation of chemical structure (a) HEA; (b) HEMA; (c) N, 
N’-methylene-bisacrylamide (BIS); (d) propagation of 
PHEAG; (e) propagation of PHEMAG. 
 
5.7 
Figure 5.4 Normalised Raman intensity of C-C stretching showing the 
formation of PHEAG at (a) 2%, (b) 3%, (c) 4%, and (4) 
5% HEA and for different BIS concentrations at 5 mM 
ascorbic acid. 
 
5.10 
Figure 5.5 Normalised Raman intensity of C-C stretching showing the 
formation of PHEAG at (a) 2%, (b) 3%, (c) 4%, and (4) 
5% HEA and for different BIS concentrations at 10 mM 
ascorbic acid. 
 
5.11 
Figure 5.6 Normalised Raman intensity of C-C stretching showing the 
formation of PHEAG at (a) 2%, (b) 3%, (c) 4%, and (4) 
5% HEA and for different BIS concentrations at 15 mM 
ascorbic acid. 
 
5.12 
Figure 5.7 Correlation between Do and the initial concentration of 
HEA for different BIS concentration at (a) 5 mM, (b) 10 
mM and (c) 15 mM ascorbic acid for the formation of 
PHEAG due to C-C stretching at 812 cm-1. 
 
5.14 
Figure 5.8 Normalised Raman intensity of C-C stretching showing the 
formation of PHEAG at (a) 1%, (b) 2%, (c) 3%, and (4) 
4% BIS and for different HEA concentrations at 5 mM 
ascorbic acid. 
 
5.16 
Figure 5.9 Normalised Raman intensity of C-C stretching showing the 
formation of PHEAG at (a) 1%, (b) 2%, (c) 3%, and (4) 
4% BIS and for different HEA concentrations at 10 mM 
ascorbic acid. 
 
5.17 
Figure 5.10 Normalised Raman intensity of C-C stretching showing the 
formation of PHEAG at (a) 1%, (b) 2%, (c) 3%, and (4) 
4% BIS and for different HEA concentrations at 15 mM 
ascorbic acid. 
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Figure 5.11 Dose correlation factor kBIS of C-C stretching at 812 cm-1 
of PHEAG due to BIS crosslinking at (a) 5 mM, (b) 10 
mM and (c) 15 mM ascorbic acid.  
 
5.20 
Figure 5.12 Normalised Raman intensity of C-C stretching (812 cm-1) 
showing the formation of PHEAG at (a) 2% HEA 1% BIS, 
(b) 3% HEA 1% BIS, (c) 4% HEA 1% BIS and (d) 5% 
HEA 1% BIS for different ascorbic acid concentration. 
 
5.22 
Figure 5.13 Normalised Raman intensity of C-C stretching (812 cm-1) 
showing the formation of PHEAG at (a) 2% HEA 2% BIS, 
(b) 3% HEA 2% BIS, (c) 4% HEA 2% BIS and (d) 5% 
HEA 2% BIS for different ascorbic acid concentration. 
 
5.23 
Figure 5.14 Normalised Raman intensity of C-C stretching (812 cm-1) 
showing the formation of PHEAG at (a) 2% HEA 3% BIS, 
(b) 3% HEA 3% BIS, (c) 4% HEA 3% BIS and (d) 5% 
HEA 3% BIS for different ascorbic acid concentration. 
 
5.24 
Figure 5.15 Normalised Raman intensity of C-C stretching (812 cm-1) 
showing the formation of PHEAG at (a) 2% HEA 4% BIS, 
(b) 3% HEA 4% BIS, (c) 4% HEA 4% BIS and (d) 5% 
HEA 4% BIS for different ascorbic acid concentration. 
 
5.25 
Figure 5.16 Normalised Raman intensity of C=C stretching of HEA 
showing the consumption of HEA at (a) 1%, (b) 2%, (c) 
3%, and (4) 4% BIS and for different HEA concentrations 
at 5 mM ascorbic acid. 
 
5.27 
Figure 5.17 Normalised Raman intensity of C=C stretching of HEA 
showing the consumption of HEA at (a) 1%, (b) 2%, (c) 
3%, and (4) 4% BIS and for different HEA concentrations 
at 10 mM ascorbic acid. 
 
5.28 
Figure 5.18 Normalised Raman intensity of C=C stretching of HEA 
showing the consumption of HEA at (a) 1%, (b) 2%, (c) 
3%, and (4) 4% BIS and for different HEA concentrations 
at 15 mM ascorbic acid. 
 
5.29 
Figure 5.19 Correlation between Do and the initial concentration of 
HEA for different BIS composition at (a) 5 mM, (b) 10 
mM and (c) 15 mM ascorbic acid for the consumption of 
monomer at C=C stretching (2887 cm-1). 
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Figure 5.20 Normalised Raman intensity of C=C stretching (2887 cm-1) 
showing the formation of PHEAG at (a) 2% HEA 1% BIS, 
(b) 3% HEA 1% BIS, (c) 4% HEA 1% BIS and (d) 5% 
HEA 1% BIS for different ascorbic acid concentration. 
 
5.33 
Figure 5.21 Normalised Raman intensity of C=C stretching (2887 cm-1) 
showing the formation of PHEAG at (a) 2% HEA 2% BIS, 
(b) 3% HEA 2% BIS, (c) 4% HEA 2% BIS and (d) 5% 
HEA 2% BIS for different ascorbic acid concentration. 
 
5.34 
 
Figure 5.22 Normalised Raman intensity of C=C stretching (2887 cm-1) 
showing the formation of PHEAG at (a) 2% HEA 3% BIS, 
(b) 3% HEA 3% BIS, (c) 4% HEA 3% BIS and (d) 5% 
HEA 3% BIS for different ascorbic acid concentration. 
 
5.35 
Figure 5.23 Normalised Raman intensity of C=C stretching (2887 cm-1) 
showing the formation of PHEAG at (a) 2% HEA 4% BIS, 
(b) 3% HEA 4% BIS, (c) 4% HEA 4% BIS and (d) 5% 
HEA 4% BIS for different ascorbic acid concentration. 
 
5.36 
Figure 5.24 Normalised Raman intensity of C=C stretching of BIS 
showing the consumption of BIS at (a) 2%, (b) 3%, (c) 4%, 
and (4) 5% HEA and for different BIS concentrations at 5 
mM ascorbic acid. 
5.38 
 
Figure 5.25 Normalised Raman intensity of C=C stretching of BIS 
showing the consumption of BIS at (a) 2%, (b) 3%, (c) 4%, 
and (4) 5% HEA and for different BIS concentrations at 10 
mM ascorbic acid. 
 
5.39 
Figure 5.26 Normalised Raman intensity of C=C stretching of BIS 
showing the consumption of BIS at (a) 2%, (b) 3%, (c) 4%, 
and (4) 5% HEA and for different BIS concentrations at 15 
mM ascorbic acid. 
 
5.40 
Figure 5.27 Correlation between Do and the initial concentration of BIS 
for different HEA composition at (a) 5 mM, (b) 10 mM 
and 15 mM ascorbic acid for the consumption of 
crosslinker at C=C stretching (2377 cm-1). 
 
5.42 
Figure 5.28 Normalised Raman intensity of C=C stretching (2377 cm-1) 
showing the formation of PHEAG at (a) 1% BIS 2% HEA, 
(b) 2% BIS 2% HEA, (c) 3% BIS 2% HEA and (d) 4% BIS 
2% HEA for different ascorbic acid concentration. 
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Figure 5.29 Normalised Raman intensity of C=C stretching (2377 cm-1) 
showing the formation of PHEAG at (a) 1% BIS 3% HEA, 
(b) 2% BIS 3% HEA, (c) 3% BIS 3% HEA and (d) 4% BIS 
3% HEA for different ascorbic acid concentration. 
 
5.44 
Figure 5.30 Normalised Raman intensity of C=C stretching (2377 cm-1) 
showing the formation of PHEAG at (a) 1% BIS 4% HEA, 
(b) 2% BIS 4% HEA, (c) 3% BIS 4% HEA and (d) 4% BIS 
4% HEA for different ascorbic acid concentration. 
 
5.45 
Figure 5.31 Normalised Raman intensity of C=C stretching (2377 cm-1) 
showing the formation of PHEAG at (a) 1% BIS 5% HEA, 
(b) 2% BIS 5% HEA, (c) 3% BIS 5% HEA and (d) 4% 
BIS 5% HEA for different ascorbic acid concentration. 
 
5.46 
Figure 5.32 Normalised Raman intensity of C-C stretching showing the 
formation of PHEMAG at (a) 2%, (b) 3%, (c) 4%, and (4) 
5% HEMA and for different BIS concentrations at 5 mM 
ascorbic acid. 
 
5.48 
Figure 5.33 Normalised Raman intensity of C-C stretching showing the 
formation of PHEMAG at (a) 2%, (b) 3%, (c) 4%, and (4) 
5% HEMA and for different BIS concentrations at 10 mM 
ascorbic acid. 
5.49 
 
Figure 5.34 Normalised Raman intensity of C-C stretching showing the 
formation of PHEMAG at (a) 2%, (b) 3%, (c) 4%, and (4) 
5% HEMA and for different BIS concentrations at 15 mM 
ascorbic acid. 
 
5.50 
Figure 5.35 Correlation between Do and the initial concentration of 
HEMA for different BIS concentration at (a) 5 mM, (b) 10 
mM and (c) 15 mM ascorbic acid for the formation of 
PHEMAG due to C-C stretching at 812 cm-1. 
 
5.52 
Figure 5.36 Normalised Raman intensity of C-C stretching showing the 
formation of PHEMAG at (a) 1%, (b) 2%, (c) 3%, and (4) 
4% BIS and for different HEMA concentrations at 5 mM 
ascorbic acid. 
 
5.54 
Figure 5.37 Normalised Raman intensity of C-C stretching showing the 
formation of PHEMAG at (a) 1%, (b) 2%, (c) 3%, and (4) 
4% BIS and for different HEMA concentrations at 10 mM 
ascorbic acid. 
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